Announcement • Jun 09
Wesure Global Tech Ltd, Annual General Meeting, Jul 09, 2026 Wesure Global Tech Ltd, Annual General Meeting, Jul 09, 2026. Upcoming Dividend • Jun 03
Upcoming dividend of ₪0.13 per share Eligible shareholders must have bought the stock before 10 June 2026. Payment date: 23 June 2026. Payout ratio is a comfortable 12% and this is well supported by cash flows. Trailing yield: 2.3%. Lower than top quartile of Israeli dividend payers (5.5%). Lower than average of industry peers (2.8%). Reported Earnings • May 11
Full year 2025 earnings released: EPS: ₪2.98 (vs ₪0.80 in FY 2024) Full year 2025 results: EPS: ₪2.98 (up from ₪0.80 in FY 2024). Revenue: ₪4.23b (down 2.1% from FY 2024). Net income: ₪392.4m (up 330% from FY 2024). Profit margin: 9.3% (up from 2.1% in FY 2024). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 74% per year but the company’s share price has increased by 142% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Feb 05
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₪15.01, the stock trades at a trailing P/E ratio of 12.6x. Average trailing P/E is 14x in the Insurance industry in Israel. Total returns to shareholders of 590% over the past three years. Valuation Update With 7 Day Price Move • Dec 25
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to ₪13.07, the stock trades at a trailing P/E ratio of 10x. Average trailing P/E is 13x in the Insurance industry in Israel. Total returns to shareholders of 556% over the past three years. Reported Earnings • Dec 02
Third quarter 2025 earnings released: EPS: ₪0.58 (vs ₪0.12 in 3Q 2024) Third quarter 2025 results: EPS: ₪0.58 (up from ₪0.12 in 3Q 2024). Revenue: ₪1.09b (down 6.5% from 3Q 2024). Net income: ₪76.5m (up 474% from 3Q 2024). Profit margin: 7.0% (up from 1.1% in 3Q 2024). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 69% per year but the company’s share price has increased by 86% per year, which means it is tracking significantly ahead of earnings growth. New Risk • Nov 26
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Israeli stocks, typically moving 7.5% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. This is currently the only risk that has been identified for the company. Valuation Update With 7 Day Price Move • Nov 11
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₪11.60, the stock trades at a trailing P/E ratio of 9.8x. Average trailing P/E is 13x in the Insurance industry in Israel. Total returns to shareholders of 426% over the past three years. Announcement • Oct 13
Wesure Global Tech Ltd, Annual General Meeting, Nov 13, 2025 Wesure Global Tech Ltd, Annual General Meeting, Nov 13, 2025. Location: co. offices, Israel Reported Earnings • Aug 26
Second quarter 2025 earnings released: EPS: ₪0.73 (vs ₪0.52 in 2Q 2024) Second quarter 2025 results: EPS: ₪0.73 (up from ₪0.52 in 2Q 2024). Revenue: ₪1.11b (up 17% from 2Q 2024). Net income: ₪95.9m (up 67% from 2Q 2024). Profit margin: 8.6% (up from 6.0% in 2Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 69% per year but the company’s share price has only increased by 54% per year, which means it is significantly lagging earnings growth. New Risk • Aug 23
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Israeli stocks, typically moving 7.5% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (7.5% average weekly change). Minor Risk Shareholders have been diluted in the past year (18% increase in shares outstanding). Valuation Update With 7 Day Price Move • Jul 22
Investor sentiment improves as stock rises 19% After last week's 19% share price gain to ₪8.54, the stock trades at a trailing P/E ratio of 14.6x. Average trailing P/E is 15x in the Insurance industry in Israel. Total returns to shareholders of 272% over the past three years. Buy Or Sell Opportunity • Jun 26
Now 23% overvalued after recent price rise Over the last 90 days, the stock has risen 35% to ₪6.61. The fair value is estimated to be ₪5.37, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 60% over the last 3 years. Meanwhile, the company has become profitable. Valuation Update With 7 Day Price Move • Jun 11
Investor sentiment improves as stock rises 23% After last week's 23% share price gain to ₪5.89, the stock trades at a trailing P/E ratio of 10.1x. Average trailing P/E is 11x in the Insurance industry in Israel. Total returns to shareholders of 174% over the past three years. Reported Earnings • Jun 03
First quarter 2025 earnings released: EPS: ₪0.20 (vs ₪0.067 in 1Q 2024) First quarter 2025 results: EPS: ₪0.20 (up from ₪0.067 in 1Q 2024). Revenue: ₪1.48b (up 38% from 1Q 2024). Net income: ₪20.6m (up 175% from 1Q 2024). Profit margin: 1.4% (up from 0.7% in 1Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 77% per year but the company’s share price has only increased by 25% per year, which means it is significantly lagging earnings growth. New Risk • May 06
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Israeli stocks, typically moving 8.3% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (8.3% average weekly change). Minor Risk Shareholders have been diluted in the past year (18% increase in shares outstanding). Buy Or Sell Opportunity • Apr 10
Now 29% overvalued Over the last 90 days, the stock has fallen 3.7% to ₪4.71. The fair value is estimated to be ₪3.64, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 72% over the last 3 years. Earnings per share has grown by 85%. Reported Earnings • Mar 20
Full year 2024 earnings released: EPS: ₪0.80 (vs ₪0.35 in FY 2023) Full year 2024 results: EPS: ₪0.80 (up from ₪0.35 in FY 2023). Revenue: ₪4.34b (up 22% from FY 2023). Net income: ₪91.3m (up 135% from FY 2023). Profit margin: 2.1% (up from 1.1% in FY 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 85% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth. Announcement • Mar 19
Wesure Global Tech Ltd Announces Annual Dividend, Payable on April 06, 2025 Wesure Global Tech Ltd. announced Annual dividend of ILS 0.1524 per share payable on April 06, 2025, ex-date on March 26, 2025 and record date on March 26, 2025. Valuation Update With 7 Day Price Move • Mar 18
Investor sentiment improves as stock rises 22% After last week's 22% share price gain to ₪5.23, the stock trades at a trailing P/E ratio of 7x. Average trailing P/E is 11x in the Insurance industry in Israel. Total returns to shareholders of 2.9% over the past three years. New Risk • Jan 23
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 18% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. This is currently the only risk that has been identified for the company. New Risk • Jan 12
New major risk - Financial data availability The company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risks Share price has been volatile over the past 3 months (5.9% average weekly change). Shareholders have been diluted in the past year (4.8% increase in shares outstanding). Reported Earnings • Dec 03
Third quarter 2024 earnings released: EPS: ₪0.12 (vs ₪0.13 in 3Q 2023) Third quarter 2024 results: EPS: ₪0.12 (down from ₪0.13 in 3Q 2023). Revenue: ₪1.17b (up 44% from 3Q 2023). Net income: ₪13.3m (down 9.1% from 3Q 2023). Profit margin: 1.1% (down from 1.8% in 3Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 94% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth. Announcement • Nov 20
Wesure Global Tech Ltd to Report Q3, 2024 Results on Nov 27, 2024 Wesure Global Tech Ltd announced that they will report Q3, 2024 results on Nov 27, 2024 Valuation Update With 7 Day Price Move • Nov 02
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₪3.91, the stock trades at a trailing P/E ratio of 4.6x. Average trailing P/E is 7x in the Insurance industry in Israel. Total loss to shareholders of 29% over the past three years. Buy Or Sell Opportunity • Oct 27
Now 20% overvalued after recent price rise Over the last 90 days, the stock has risen 26% to ₪3.47. The fair value is estimated to be ₪2.88, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 90% over the last 3 years. Earnings per share has grown by 85%. Reported Earnings • Aug 31
Second quarter 2024 earnings released: EPS: ₪0.52 (vs ₪0.004 in 2Q 2023) Second quarter 2024 results: EPS: ₪0.52 (up from ₪0.004 in 2Q 2023). Revenue: ₪952.2m (flat on 2Q 2023). Net income: ₪57.5m (up ₪57.0m from 2Q 2023). Profit margin: 6.0% (up from 0.1% in 2Q 2023). Over the last 3 years on average, earnings per share has increased by 85% per year but the company’s share price has fallen by 13% per year, which means it is significantly lagging earnings. New Risk • Aug 27
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 4.8% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (8.8% average weekly change). Minor Risks Shareholders have been diluted in the past year (4.8% increase in shares outstanding). Market cap is less than US$100m (₪335.6m market cap, or US$91.3m). Valuation Update With 7 Day Price Move • Jul 09
Investor sentiment improves as stock rises 24% After last week's 24% share price gain to ₪2.63, the stock trades at a trailing P/E ratio of 6.9x. Average trailing P/E is 9x in the Insurance industry in Israel. Total loss to shareholders of 62% over the past three years. Buy Or Sell Opportunity • Jun 09
Now 21% undervalued Over the last 90 days, the stock has risen 28% to ₪2.47. The fair value is estimated to be ₪3.12, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 97% over the last 3 years. Earnings per share has grown by 66%. Reported Earnings • Jun 04
First quarter 2024 earnings released: EPS: ₪0.07 (vs ₪0.037 in 1Q 2023) First quarter 2024 results: EPS: ₪0.07 (up from ₪0.037 in 1Q 2023). Revenue: ₪1.08b (up 43% from 1Q 2023). Net income: ₪7.50m (up 84% from 1Q 2023). Profit margin: 0.7% (up from 0.5% in 1Q 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 66% per year but the company’s share price has fallen by 23% per year, which means it is significantly lagging earnings. Valuation Update With 7 Day Price Move • Jun 02
Investor sentiment improves as stock rises 19% After last week's 19% share price gain to ₪3.01, the stock trades at a trailing P/E ratio of 8.6x. Average trailing P/E is 11x in the Insurance industry in Israel. Total loss to shareholders of 53% over the past three years. Announcement • Jun 01
Wesure Global Tech Ltd, Annual General Meeting, Jul 04, 2024 Wesure Global Tech Ltd, Annual General Meeting, Jul 04, 2024. Location: co. offices, Israel New Risk • May 29
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Israeli stocks, typically moving 8.0% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (8.0% average weekly change). Minor Risks Profit margins are more than 30% lower than last year (1.1% net profit margin). Market cap is less than US$100m (₪338.4m market cap, or US$91.3m). New Risk • Mar 31
New minor risk - Profit margin trend The company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 1.1% Last year net profit margin: 1.6% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (6.5% average weekly change). Profit margins are more than 30% lower than last year (1.1% net profit margin). Market cap is less than US$100m (₪256.3m market cap, or US$69.5m). Reported Earnings • Mar 31
Full year 2023 earnings released: EPS: ₪0.35 (vs ₪0.22 in FY 2022) Full year 2023 results: EPS: ₪0.35 (up from ₪0.22 in FY 2022). Revenue: ₪3.56b (up 187% from FY 2022). Net income: ₪38.9m (up 99% from FY 2022). Profit margin: 1.1% (down from 1.6% in FY 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 64% per year but the company’s share price has fallen by 33% per year, which means it is significantly lagging earnings. Valuation Update With 7 Day Price Move • Mar 29
Investor sentiment improves as stock rises 23% After last week's 23% share price gain to ₪2.30, the stock trades at a trailing P/E ratio of 8.5x. Average trailing P/E is 12x in the Insurance industry in Israel. Total loss to shareholders of 70% over the past three years. Valuation Update With 7 Day Price Move • Feb 13
Investor sentiment improves as stock rises 21% After last week's 21% share price gain to ₪1.77, the stock trades at a trailing P/E ratio of 6.6x. Average trailing P/E is 11x in the Insurance industry in Israel. Total loss to shareholders of 22% over the past year. Reported Earnings • Dec 02
Third quarter 2023 earnings released: EPS: ₪0.13 (vs ₪0.23 in 3Q 2022) Third quarter 2023 results: EPS: ₪0.13 (down from ₪0.23 in 3Q 2022). Revenue: ₪813.4m (up 58% from 3Q 2022). Net income: ₪14.7m (down 23% from 3Q 2022). Profit margin: 1.8% (down from 3.7% in 3Q 2022). Valuation Update With 7 Day Price Move • Nov 24
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to ₪1.29, the stock trades at a trailing P/E ratio of 4.2x. Average trailing P/E is 12x in the Insurance industry in Israel. Total loss to shareholders of 40% over the past year. Reported Earnings • Aug 31
Second quarter 2023 earnings released: EPS: ₪0.004 (vs ₪0.074 loss in 2Q 2022) Second quarter 2023 results: EPS: ₪0.004 (up from ₪0.074 loss in 2Q 2022). Revenue: ₪956.9m (up ₪923.9m from 2Q 2022). Net income: ₪482.0k (up ₪5.66m from 2Q 2022). Profit margin: 0.1% (up from net loss in 2Q 2022). Valuation Update With 7 Day Price Move • Aug 07
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to ₪1.34, the stock trades at a trailing P/E ratio of 5.2x. Average trailing P/E is 12x in the Insurance industry in Israel. Total loss to shareholders of 38% over the past year. New Risk • Jul 20
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Israeli stocks, typically moving 8.6% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (8.6% average weekly change). Shareholders have been substantially diluted in the past year (70% increase in shares outstanding). Minor Risks Large one-off items impacting financial results. Market cap is less than US$100m (₪182.5m market cap, or US$50.8m). Valuation Update With 7 Day Price Move • Jul 19
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to ₪1.64, the stock trades at a trailing P/E ratio of 6.4x. Average trailing P/E is 12x in the Insurance industry in Israel. Total loss to shareholders of 31% over the past year. Valuation Update With 7 Day Price Move • Jun 07
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to ₪1.57, the stock trades at a trailing P/E ratio of 6x. Average trailing P/E is 10x in the Insurance industry in Israel. Total loss to shareholders of 38% over the past year. Reported Earnings • Jun 03
First quarter 2023 earnings released: EPS: ₪0.04 (vs ₪0.08 loss in 1Q 2022) First quarter 2023 results: EPS: ₪0.04 (up from ₪0.08 loss in 1Q 2022). Revenue: ₪755.4m (up ₪720.5m from 1Q 2022). Net income: ₪4.09m (up ₪9.10m from 1Q 2022). Profit margin: 0.5% (up from net loss in 1Q 2022). Valuation Update With 7 Day Price Move • May 17
Investor sentiment improves as stock rises 24% After last week's 24% share price gain to ₪1.56, the stock trades at a trailing P/E ratio of 8.7x. Average trailing P/E is 8x in the Insurance industry in Israel. Total loss to shareholders of 47% over the past year.